Pharmaceuticals, Biotechnology and Life Sciences
First publication of complete results shows improvement across both objective measures of attention and parent and clinician ratings of ADHD…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sesen Bio (Nasdaq: SESN) a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients…
Revenue of $229.9 million in the fourth quarter of 2019 increased 19.7% from revenue of $192.1 million for the comparable…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the Cowen 40th Annual Health…
– Conference call and webcast today at 4:30 p.m. ET – NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology…
SAN FRANCISCO–(BUSINESS WIRE)–#DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA…
Rubraca® (rucaparib) net product revenue totaled $143.0M for 2019 and $39.3M for Q4 2019 Net product revenue for 2019 up…
DUBLIN–(BUSINESS WIRE)–The “Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development” report has been added to ResearchAndMarkets.com’s offering. Novel…
ALLENDALE, Mich.–(BUSINESS WIRE)–Abond CRO Inc. announced today the hiring of Mr. Charley Bratton as Senior Vice President Corporate Marketing and…
DUBLIN–(BUSINESS WIRE)–The “Laboratory Automation Market by Product Type Application and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026” report…